Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CALCR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
VPS50 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HEPACAM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SAMD9L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TFPI2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SAMD9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GNGT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GNG11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BET1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COL1A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on